DARZALEX

Google image searchProduct monograph

Active ingredient

daratumumab, 100 MG/5 ML

DIN: 02455951

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: JANSSEN INC

Date: 12-JUL-2016

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FC — CD38 (Clusters of Differentiation 38) inhibitors (ATC, ATC/DDD)
• L01FC01 — DARATUMUMAB (ATC/DDD)

Reference brand drug: Darzalex

External Links for Darzalex

Search on Google

• Darzalex side effects
• Darzalex dosage
• daratumumab side effects
• daratumumab dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find darzalex photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.